Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

APOC2 Gene Apolipoprotein C-II Deficiency Genetic Test in UAE | 2,800 AED | DHA Licensed

Executive Summary & Core Metrics

  • Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 certified NGS, ensuring definitive detection of all APOC2 gene mutations.
  • Premium Logistics: Hospital-grade cold-chain home collection across UAE, VIP mobile phlebotomy, and strict sample integrity from vein to sequencer.
  • Clinical Guidance: Telephonic post-test genetic counselling by a DHA-licensed Consultant Medical Genetics for result interpretation and family cascade planning.
  • Insurance: Direct billing verification via WhatsApp +971 54 548 8731 – fast pre-approval for most UAE insurers.

Test Overview & Methodology

The APOC2 genetic test uses Next-Generation Sequencing (NGS) to identify pathogenic variants in the APOC2 gene that cause Apolipoprotein C-II deficiency—a rare autosomal recessive metabolic disorder leading to severe hypertriglyceridemia, recurrent pancreatitis, and accelerated cardiovascular risk. This definitive DNA analysis enables accurate molecular diagnosis, family cascade screening, and tailored lipid management in accordance with DHA cardiometabolic guidelines.

Feature Our APOC2 NGS Test Closest Alternative (Targeted Genotyping)
Methodology Full-gene NGS (all exons, splice sites, and regulatory regions) Limited mutation panel (only common hot-spots)
Diagnostic Sensitivity >99.9% (captures novel and private variants) ~70% (misses rare mutations)
Turnaround Time 3–4 Weeks 4–6 Weeks (often sent abroad)
Accreditation ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139), DHA Licensed Limited QA/QC oversight
Price (AED) 2,800 2,200–3,500 (variable cost)

Physician Insight & Safety Protocols

“As a DHA-licensed Consultant Medical Genetics, I reassure every patient that an APOC2 result provides clarity, not finality. This test accurately identifies the genetic basis of severe hypertriglyceridemia, enabling targeted management and family cascade screening. However, genetic results must always be interpreted alongside the full lipid profile, clinical history, and physical examination. Never discontinue prescribed fibrates or omega-3 therapy without consulting your specialist—genetic insight complements, but never replaces, comprehensive clinical care.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Medication Advisory

⚠️ Do not discontinue any prescribed lipid-lowering medication or insulin regimen without consulting your treating physician. Abrupt cessation can provoke acute pancreatitis and metabolic decompensation.

Patient Safety Exclusion Criteria & ER Red Flags

  • If you are currently experiencing acute pancreatitis (severe abdominal pain radiating to the back, vomiting), seek emergency care immediately—do not rely solely on genetic testing.
  • Minors (under 18) require a legal guardian's signed consent and a pre-test genetic counselling session in compliance with UAE regulations.
  • Pregnant women should inform their doctor; while the blood draw is safe, anxiety management and informed consent are essential.
  • Individuals unable to provide informed consent or with unstable medical conditions should postpone elective genetic testing.

🚨 ER Red Flags: Sudden onset of intense abdominal pain radiating to the back, nausea, vomiting, fever, or yellowish fatty deposits on the skin (eruptive xanthomas) – visit the nearest emergency department immediately.

Patient FAQ & Clinical Guidance

1. What is the APOC2 gene test used for?

Snippet Answer: This precise genetic test detects all known pathogenic variants in the APOC2 gene to definitively diagnose Apolipoprotein C-II deficiency. It is indicated for individuals with severe hypertriglyceridemia (>885 mg/dL), recurrent pancreatitis of unknown origin, or a family history of unexplained lipid disorders, allowing accurate molecular confirmation and differentiation from other familial hyperlipidemias.

2. How does the NGS method ensure high accuracy and what sample is required?

Snippet Answer: NGS technology reads every base of the APOC2 gene multiple times at high depth, achieving >99.9% sensitivity. A simple peripheral whole blood sample is collected by our mobile phlebotomy team and transported in ISO-certified cold-chain logistics to preserve DNA integrity. Alternative specimen types include extracted DNA or dried blood spot (FTA card) upon prior arrangement.

3. Are the results confidential and compliant with UAE data-protection laws?

Snippet Answer: Absolutely; all genetic data is anonymized and protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and stored on encrypted servers. Your identifiable information is never shared without explicit written consent, and reports are released only to you or your authorized physician. Additionally, all electronic health data handling complies with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.

UAE Regulatory & Data Privacy Adherence

Regulatory Compliance: This genetic test is performed in full adherence with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical safety and patient consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory holds DHA Facility License Number 1143 and is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139). Corporate oversight is provided by DNA Labs UAE.

Clinical & Logistical Metadata

Test Name APOC2 Gene Apolipoprotein C-II Deficiency Genetic Test (NGS)
Price (AED) 2,800
Turnaround Time 3–4 Weeks
Sample Type / Matrix Peripheral Whole Blood (VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM – 11 PM)
Methodology Used Next-Generation Sequencing (NGS) – Full gene, high coverage
ICD-10-CM Code E78.1 (Pure hyperglyceridemia)
LOINC Code 48767-8 (APOC2 gene mutation analysis)
DHA Facility License & Laboratory Address License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians